AYBINTIO
AYBINTIO
Approved
DIN Number
02522829
Drug Class
Human
Market Date
Jun 27, 2022
Company
HC
Samsung Bioepis Co., Ltd.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02522829
AIG Number0151381001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription Recommended
,
Schedule D
A
ATC Code
L01FG01 BEVACIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
BEVACIZUMABActive
Strength: 100 MG / 4 ML
Monograph: BEVACIZUMAB